Read + Share
Amedeo Smart
Independent Medical Education
Kohn OF. In CKD, the effect of dapagliflozin on kidney outcomes did not vary by T2DM status or CKD cause. Ann Intern Med 2021;174:JC53.PMID: 33939480
Email
LinkedIn
Facebook
Twitter
Privacy Policy